| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| GRF.MC - Grifols SA | HOLD | 0 @ 10.42 | 0 | |
| DIA.MI - DiaSorin SpA | SELL | -20 @ 96.42 | -1,928 | The ETF sold 20 shares of DIA.MI on 2025-03-07. The shares were previously bought for an average price of 100.333. The DiaSorin SpA shares were sold for -3.9% lower than average price of previous purchases. This resulted in an overall loss of 78 |
| AMP.MI - Amplifon SpA | SELL | -109 @ 20.86 | -2,274 | The ETF sold 109 shares of AMP.MI on 2025-03-07. The shares were previously bought for an average price of 24.7876. The Amplifon SpA shares were sold for -15.8% lower than average price of previous purchases. This resulted in an overall loss of 428 |
| DEMANT.CO - | SELL | -78 @ 33.9751 | -2,650 | The ETF sold 78 shares of DEMANT.CO on 2025-03-07. The shares were previously bought for an average price of 35.2402. The shares were sold for -3.6% lower than average price of previous purchases. This resulted in an overall loss of 99 |
| IPN.PA - Ipsen SA | SELL | -33 @ 110 | -3,630 | The ETF sold 33 shares of IPN.PA on 2025-03-07. The shares were previously bought for an average price of 110.607. The Ipsen SA shares were sold for -0.5% lower than average price of previous purchases. This resulted in an overall loss of 20 |
| HIK.L - | SELL | -145 @ 25.2525 | -3,662 | The ETF sold 145 shares of HIK.L on 2025-03-07. The shares were previously bought for an average price of 24.7278. The shares were sold for 2.1% higher than average price of previous purchases. This sale made a profit of 76 |
| ZEAL.CO - | SELL | -55 @ 71.5301 | -3,934 | The ETF sold 55 shares of ZEAL.CO on 2025-03-07. The shares were previously bought for an average price of 96.3373. The shares were sold for -25.8% lower than average price of previous purchases. This resulted in an overall loss of 1,364 |
| BIM.PA - BioMerieux | SELL | -36 @ 115.3 | -4,151 | The ETF sold 36 shares of BIM.PA on 2025-03-07. The shares were previously bought for an average price of 103.835. The BioMerieux shares were sold for 11.0% higher than average price of previous purchases. This sale made a profit of 413 |
| SOBI.ST - | SELL | -168 @ 26.9291 | -4,524 | The ETF sold 168 shares of SOBI.ST on 2025-03-07. The shares were previously bought for an average price of 27.7773. The shares were sold for -3.1% lower than average price of previous purchases. This resulted in an overall loss of 142 |
| DIM.PA - Sartorius Stedim Biotech | SELL | -25 @ 193.1 | -4,828 | The ETF sold 25 shares of DIM.PA on 2025-03-07. The shares were previously bought for an average price of 188.831. The Sartorius Stedim Biotech shares were sold for 2.3% higher than average price of previous purchases. This sale made a profit of 107 |
| ORNBV.HE - Orion Oyj | SELL | -94 @ 53.54 | -5,033 | The ETF sold 94 shares of ORNBV.HE on 2025-03-07. The shares were previously bought for an average price of 45.9285. The Orion Oyj shares were sold for 16.6% higher than average price of previous purchases. This sale made a profit of 715 |
| SRT3.DE - Sartorius AG | SELL | -23 @ 229 | -5,267 | The ETF sold 23 shares of SRT3.DE on 2025-03-07. The shares were previously bought for an average price of 222.467. The Sartorius AG shares were sold for 2.9% higher than average price of previous purchases. This sale made a profit of 150 |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | SELL | -99 @ 53.55 | -5,301 | The ETF sold 99 shares of REC.MI on 2025-03-07. The shares were previously bought for an average price of 52.9455. The Recordati Industria Chimica e Farmaceutica SpA shares were sold for 1.1% higher than average price of previous purchases. This sale made a profit of 60 |
| ERF.PA - Eurofins Scientific SE | SELL | -117 @ 51.36 | -6,009 | The ETF sold 117 shares of ERF.PA on 2025-03-07. The shares were previously bought for an average price of 48.5105. The Eurofins Scientific SE shares were sold for 5.9% higher than average price of previous purchases. This sale made a profit of 333 |
| QIA.DE - QIAGEN NV | SELL | -186 @ 36.51 | -6,791 | The ETF sold 186 shares of QIA.DE on 2025-03-07. The shares were previously bought for an average price of 37.679. The QIAGEN NV shares were sold for -3.1% lower than average price of previous purchases. This resulted in an overall loss of 217 |
| GALD.SW - | SELL | -72 @ 104.104 | -7,495 | The ETF sold 72 shares of GALD.SW on 2025-03-07. The shares were previously bought for an average price of 99.0685. The shares were sold for 5.1% higher than average price of previous purchases. This sale made a profit of 363 |
| FME.DE - Fresenius Medical Care AG | SELL | -177 @ 44.02 | -7,792 | The ETF sold 177 shares of FME.DE on 2025-03-07. The shares were previously bought for an average price of 44.3285. The Fresenius Medical Care AG shares were sold for -0.7% lower than average price of previous purchases. This resulted in an overall loss of 55 |
| RO.SW - | SELL | -28 @ 338.777 | -9,486 | The ETF sold 28 shares of RO.SW on 2025-03-07. The shares were previously bought for an average price of 298.891. The shares were sold for 13.3% higher than average price of previous purchases. This sale made a profit of 1,117 |
| SN.L - Smith & Nephew PLC | SELL | -715 @ 13.7141 | -9,806 | The ETF sold 715 shares of SN.L on 2025-03-07. The shares were previously bought for an average price of 12.9571. The Smith & Nephew PLC shares were sold for 5.8% higher than average price of previous purchases. This sale made a profit of 541 |
| COLO-B.CO - | SELL | -108 @ 99.2975 | -10,724 | The ETF sold 108 shares of COLO-B.CO on 2025-03-07. The shares were previously bought for an average price of 105.344. The shares were sold for -5.7% lower than average price of previous purchases. This resulted in an overall loss of 653 |
| STMN.SW - | SELL | -96 @ 123.325 | -11,839 | The ETF sold 96 shares of STMN.SW on 2025-03-07. The shares were previously bought for an average price of 124.037. The shares were sold for -0.6% lower than average price of previous purchases. This resulted in an overall loss of 68 |
| GMAB.CO - | SELL | -54 @ 222.501 | -12,015 | The ETF sold 54 shares of GMAB.CO on 2025-03-07. The shares were previously bought for an average price of 203.447. The shares were sold for 9.4% higher than average price of previous purchases. This sale made a profit of 1,029 |
| SOON.SW - | SELL | -44 @ 287.479 | -12,649 | The ETF sold 44 shares of SOON.SW on 2025-03-07. The shares were previously bought for an average price of 314.261. The shares were sold for -8.5% lower than average price of previous purchases. This resulted in an overall loss of 1,178 |
| SHL.DE - Siemens Healthineers AG | SELL | -243 @ 52.38 | -12,728 | The ETF sold 243 shares of SHL.DE on 2025-03-07. The shares were previously bought for an average price of 51.8309. The Siemens Healthineers AG shares were sold for 1.1% higher than average price of previous purchases. This sale made a profit of 133 |
| SDZ.SW - | SELL | -359 @ 40.6511 | -14,594 | The ETF sold 359 shares of SDZ.SW on 2025-03-07. The shares were previously bought for an average price of 40.6275. The shares were sold for 0.1% higher than average price of previous purchases. This sale made a profit of 8 |
| FRE.DE - Fresenius SE & Co KGaA | SELL | -363 @ 40.23 | -14,603 | The ETF sold 363 shares of FRE.DE on 2025-03-07. The shares were previously bought for an average price of 34.2976. The Fresenius SE & Co KGaA shares were sold for 17.3% higher than average price of previous purchases. This sale made a profit of 2,153 |
| MRK.DE - Merck KGaA | SELL | -111 @ 135.5 | -15,041 | The ETF sold 111 shares of MRK.DE on 2025-03-07. The shares were previously bought for an average price of 139.551. The Merck KGaA shares were sold for -2.9% lower than average price of previous purchases. This resulted in an overall loss of 450 |
| PHIA.AS - Koninklijke Philips NV | SELL | -687 @ 25.26 | -17,354 | The ETF sold 687 shares of PHIA.AS on 2025-03-07. The shares were previously bought for an average price of 24.6046. The Koninklijke Philips NV shares were sold for 2.7% higher than average price of previous purchases. This sale made a profit of 450 |
| BAYN.DE - Bayer AG | SELL | -845 @ 23.25 | -19,646 | The ETF sold 845 shares of BAYN.DE on 2025-03-07. The shares were previously bought for an average price of 20.0857. The Bayer AG shares were sold for 15.8% higher than average price of previous purchases. This sale made a profit of 2,674 |
| UCB.BR - UCB SA | SELL | -109 @ 188.5 | -20,547 | The ETF sold 109 shares of UCB.BR on 2025-03-07. The shares were previously bought for an average price of 187.048. The UCB SA shares were sold for 0.8% higher than average price of previous purchases. This sale made a profit of 158 |
| ARGX.BR - Argenx SE | SELL | -52 @ 555.4 | -28,881 | The ETF sold 52 shares of ARGX.BR on 2025-03-07. The shares were previously bought for an average price of 595.286. The Argenx SE shares were sold for -6.7% lower than average price of previous purchases. This resulted in an overall loss of 2,074 |
| HLN.L - Haleon PLC | SELL | -7,397 @ 4.74852 | -35,125 | The ETF sold 7397 shares of HLN.L on 2025-03-07. The shares were previously bought for an average price of 4.78282. The Haleon PLC shares were sold for -0.7% lower than average price of previous purchases. This resulted in an overall loss of 254 |
| ALC.SW - | SELL | -430 @ 84.3173 | -36,256 | The ETF sold 430 shares of ALC.SW on 2025-03-07. The shares were previously bought for an average price of 82.9152. The shares were sold for 1.7% higher than average price of previous purchases. This sale made a profit of 603 |
| LONN.SW - | SELL | -62 @ 591.917 | -36,699 | The ETF sold 62 shares of LONN.SW on 2025-03-07. The shares were previously bought for an average price of 578.592. The shares were sold for 2.3% higher than average price of previous purchases. This sale made a profit of 826 |
| GSK.L - GlaxoSmithKline PLC | SELL | -3,565 @ 18.2379 | -65,018 | The ETF sold 3565 shares of GSK.L on 2025-03-07. The shares were previously bought for an average price of 16.4181. The GlaxoSmithKline PLC shares were sold for 11.1% higher than average price of previous purchases. This sale made a profit of 6,488 |
| EL.PA - EssilorLuxottica SA | SELL | -256 @ 272 | -69,632 | The ETF sold 256 shares of EL.PA on 2025-03-07. The shares were previously bought for an average price of 242.813. The EssilorLuxottica SA shares were sold for 12.0% higher than average price of previous purchases. This sale made a profit of 7,472 |
| SAN.PA - Sanofi SA | SELL | -978 @ 109.62 | -107,208 | The ETF sold 978 shares of SAN.PA on 2025-03-07. The shares were previously bought for an average price of 94.8468. The Sanofi SA shares were sold for 15.6% higher than average price of previous purchases. This sale made a profit of 14,448 |
| NOVN.SW - | SELL | -1,695 @ 105.653 | -179,082 | The ETF sold 1695 shares of NOVN.SW on 2025-03-07. The shares were previously bought for an average price of 96.6039. The shares were sold for 9.4% higher than average price of previous purchases. This sale made a profit of 15,338 |
| AZN.L - AstraZeneca PLC | SELL | -1,334 @ 143.526 | -191,464 | The ETF sold 1334 shares of AZN.L on 2025-03-07. The shares were previously bought for an average price of 129.373. The AstraZeneca PLC shares were sold for 10.9% higher than average price of previous purchases. This sale made a profit of 18,880 |
| ROG.SW - | SELL | -604 @ 321.398 | -194,124 | The ETF sold 604 shares of ROG.SW on 2025-03-07. The shares were previously bought for an average price of 281.34. The shares were sold for 14.2% higher than average price of previous purchases. This sale made a profit of 24,195 |
| NOVO-B.CO - Novo Nordisk A/S | SELL | -2,770 @ 80.1245 | -221,945 | The ETF sold 2770 shares of NOVO-B.CO on 2025-03-07. The shares were previously bought for an average price of 86.2643. The Novo Nordisk A/S shares were sold for -7.1% lower than average price of previous purchases. This resulted in an overall loss of 17,007 |